163 related articles for article (PubMed ID: 37292146)
1. Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds.
Ahmed IA; Hafiz S; van Ginkel S; Pondugula SR; Abdelhaffez AS; Sayyed HG; El-Aziz EAA; Mansour MM
Nat Prod Commun; 2023 May; 18(5):. PubMed ID: 37292146
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
Pilling A; Kim SH; Hwang C
Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
[TBL] [Abstract][Full Text] [Related]
3. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
4. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.
Zhu S; Oremo JA; Li S; Zhen M; Tang Y; Du Y
PLoS One; 2014; 9(3):e91817. PubMed ID: 24632829
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer.
Lima TS; Souza LO; Iglesias-Gato D; Elversang J; Jørgensen FS; Kallunki T; Røder MA; Brasso K; Moreira JMA
Front Pharmacol; 2022; 13():869461. PubMed ID: 35721223
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a docetaxel-resistant human prostate cancer cell line.
Liu J; Huang Y; Zhu D; Dai Y; Liu D; Zhai Y; Liang X; Wu L; Zhao Q
Oncol Lett; 2020 Nov; 20(5):230. PubMed ID: 32968452
[TBL] [Abstract][Full Text] [Related]
9. Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.
Li YF; Ji HH; Zhang ZL; Zhang TT; Gan W; Zhang SF
Oncol Lett; 2017 Aug; 14(2):1748-1756. PubMed ID: 28789405
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.
Sato A; Itcho N; Ishiguro H; Okamoto D; Kobayashi N; Kawai K; Kasai H; Kurioka D; Uemura H; Kubota Y; Watanabe M
Int J Nanomedicine; 2013; 8():3151-60. PubMed ID: 23990723
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
12. Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells.
Inamura SO; Ito H; Taga M; Tsuchiyama K; Hoshino H; Kobayashi M; Yokoyama O
Anticancer Res; 2019 Oct; 39(10):5417-5425. PubMed ID: 31570436
[TBL] [Abstract][Full Text] [Related]
13. Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.
Cancino-Marentes ME; Hernández-Flores G; Ortiz-Lazareno PC; Villaseñor-García MM; Orozco-Alonso E; Sierra-Díaz E; Solís-Martínez RA; Cruz-Gálvez CC; Bravo-Cuellar A
BMC Urol; 2021 Mar; 21(1):38. PubMed ID: 33711972
[TBL] [Abstract][Full Text] [Related]
14. Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer.
Mao L; Yu H; Ma S; Xu Z; Wei F; Yang C; Zheng J
J Cancer; 2021; 12(6):1846-1852. PubMed ID: 33613773
[No Abstract] [Full Text] [Related]
15. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway.
Singh SK; Apata T; Gordetsky JB; Singh R
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540423
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.
Varol U; Degirmenci M; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Sanli UA; Uslu R
Tumour Biol; 2015 Feb; 36(2):779-86. PubMed ID: 25293519
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
Lian H; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
[TBL] [Abstract][Full Text] [Related]
18. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.
Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E
J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360
[No Abstract] [Full Text] [Related]
19. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells.
da Silva Guimarães G; Cordeiro AO; Gazolla MC; Vecchi L; Pereira Zoia MA; de Vasconcelos Azevedo FVP; Moreira Campos I; de Souza Costa D; Soares Mota ST; Alves Ribeiro M; Goulart LR; da Silva Filho AA; Araújo TG
Curr Top Med Chem; 2023; 23(11):943-955. PubMed ID: 36748811
[TBL] [Abstract][Full Text] [Related]
20. Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
Mathur A; Abd Elmageed ZY; Liu X; Kostochka ML; Zhang H; Abdel-Mageed AB; Mondal D
PLoS One; 2014; 9(8):e103109. PubMed ID: 25121735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
